DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis

Information source: Hoffmann-La Roche
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Post Menopausal Osteoporosis

Intervention: alendronate (Drug); ibandronate [Bonviva/Boniva] (Drug)

Phase: N/A

Status: Completed

Sponsored by: Hoffmann-La Roche

Official(s) and/or principal investigator(s):
Clinical Trials, Study Director, Affiliation: Hoffmann-La Roche


This observational study will assess the compliance and persistence of patients, real life efficacy and safety of intravenously quarterly administered 3 mg ibandronate [Bonviva/Boniva] in comparison to oral alendronate generics in female patients with post-menopausal osteoporosis. The anticipated time of assessment is 12 months. The target sample size is 5000-7000 patients.

Clinical Details

Official title: Controllability and Real Life Efficacy of Bonviva 3 mg iv Quarterly vs. Oral Alendronate Generics

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Assessment of compliance and persistence of Bonviva therapy: Number of prescriptions, number of applied injections, number of taken oral medication, continuation and duration of treatment

Secondary outcome:

Pain intensity and reduction in use of analgesics

Quality of life and patients satisfaction

Degree of patient's mobility

Incidence of new osteoporotic fractures

Controllability and management of therapy by the physician

Patient baseline characteristics

User friendliness

Safety: AEs and SAEs


Minimum age: 55 Years. Maximum age: N/A. Gender(s): Female.


Inclusion Criteria:

- Adult patients, >/= 55 years of age

- Postmenopausal osteoporosis

- Patients who are in the opinion of the physician eligible to participate in this

study Exclusion Criteria:

- N/A

Locations and Contacts

Marburg 35043, Germany
Additional Information

Starting date: April 2010
Last updated: August 17, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017